TomTom Releases New Report on U.S. Airport Road Traffic Trends

(Euronext Amsterdam:TOM2), AMSTERDAM, Dec. 01, 2025 (GLOBE NEWSWIRE) — TomTom (TOM2), the location technology specialist, today released a new report examining how road congestion around major U.S. airports shifts during the country's busiest travel periods, including the recent federal shutdown that stretched across November and contributed to widespread flight cancellations. Drawing on multi-year data across […]

Nature Genetics Study Validates Seer’s Proteograph Platform as Essential for Turning Genetic Signals Into Reliable Drug Targets and Biomarkers

(NASDAQ:SEER), REDWOOD CITY, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced the publication in Nature Genetics of a large genome-wide association study (GWAS) that used the company's Proteograph(R) Product Suite to measure proteins at peptide-level resolution and map their genetic

Cullinan Therapeutics Receives FDA Fast Track Designation for CLN-049, a Novel FLT3xCD3 T Cell Engager, in Relapsed/Refractory Acute Myeloid Leukemia

(NASDAQ:CGEM), Promising efficacy and favorable safety data from the Phase 1 study in heavily pre-treated patients show potential of CLN-049 to address a broad population of AML patients CAMBRIDGE, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) — Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a clinical-stage biopharmaceutical company accelerating potential first- or best-in-class, high-impact therapies in autoimmune diseases

Fractyl Health to Participate in the 8th Annual Evercore Healthcare Conference

(NasdaqGM:GUTS), BURLINGTON, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) — Fractyl Health, Inc. (Nasdaq: GUTS) (the Company or Fractyl), a metabolic therapeutics company focused on pattern-breaking approaches that treat root causes of obesity and type 2 diabetes (T2D), today announced that Harith Rajagopalan, M.D., Ph.D., Co-Founder and Chief Executive Officer of the Company, will be participating

Syndax Announces Participation at the 8th Annual Evercore Healthcare Conference

(NASDAQ:SNDX), NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) — Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer, will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on Thursday, December 4, 2025, at 11:15 a.m. ET. A live webcast

Edustaff Partners with Holmdel Township Public Schools, Strengthening Its Growing Presence in New Jersey

GRAND RAPIDS, Mich., Dec. 01, 2025 (GLOBE NEWSWIRE) — Edustaff, a leading provider of K-12 educational staffing solutions, is proud to announce a new partnership with Holmdel Township Public Schools in New Jersey. This collaboration marks another key milestone in Edustaff's continued expansion across the state, supporting schools with high-quality substitute and support staff. Through

Barrick Announces Evaluation of an Initial Public Offering of its North American Gold Assets

Barrick Announces Evaluation of an Initial Public Offering of its North American Gold Assets GlobeNewswire December 01, 2025 Contemplated IPO to highlight the value of North American gold assets by creating a focused publicly traded equity (“NewCo”) Barrick would maintain a significant controlling interest in NewCo Company will update market on progress at Full Year

Autolus Therapeutics Appoints Ryan Richardson to Board of Directors

Autolus Therapeutics Appoints Ryan Richardson to Board of Directors GlobeNewswire December 01, 2025 LONDON and GAITHERSBURG, Md., Dec. 01, 2025 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, today announced the appointment of Ryan Richardson to the Company's Board of

Highlander Silver Reports Record Results and New Discovery: 23.9m at 20.82 g/t Gold and 31.53 g/t Silver and 23.4m at 11.70 g/t Gold and 26.10 g/t Silver in Shallow Drilling

Highlander Silver Reports Record Results and New Discovery: 23.9m at 20.82 g/t Gold and 31.53 g/t Silver and 23.4m at 11.70 g/t Gold and 26.10 g/t Silver in Shallow Drilling GlobeNewswire December 01, 2025 TORONTO, Dec. 01, 2025 (GLOBE NEWSWIRE) — Highlander Silver Corp. (TSX: HSLV; “Highlander Silver” or the “Company“) is pleased to report

Scroll to Top